Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Patients With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02923466
Recruitment Status : Recruiting
First Posted : October 4, 2016
Last Update Posted : February 11, 2019
Sponsor:
Information provided by (Responsible Party):
Vyriad, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : February 2020